Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/1312 stock hub

HKG/1312 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1312is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

162.1M

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1312

In the news

Latest news · HKG/1312

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-67.1

P25 -14.7P50 2P75 9.4

ROIC-7.3

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1312 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

HKD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	636
Employees Change	-78%
Employees Change Percent	-10.92
Enterprise value	HKD 222.7M
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG8918D1088
Last refreshed	2026-05-10
Market cap	HKD 162.1M
Price	HKD 0.03
Price currency	HKD
Rev Per Employee	1,438,221.7x
Sector	Healthcare
Sic	3241
Symbol	hkg/1312
Website	https://www.kontafarma.com.hk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-263.99%
EV Earnings	-0.52x
EV/EBITDA	4.92x
EV/FCF	4.19x
EV/Sales	0.24x
FCF yield	32.8%
P/B ratio	0.34x
P/S ratio	0.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.91%
EBITDA Margin	-1.57%
FCF margin	5.81%
Gross margin	56.15%
Gross Profit	HKD 513.6M
Gross Profit Growth	4.05%
Gross Profit Growth Q	8.37%
Gross Profit Growth3 Y	0.82%
Gross Profit Growth5 Y	1.11%
Net Income	HKD -427.8M
Net Income Growth Years	0%
Pretax Margin	-49.71%
Profit Margin	-46.77%
Profit Per Employee	HKD -672,717
ROA	-2.12
Roa5y	-2.29
ROCE	-7.45
ROE	-67.12
Roe5y	-19.08
ROIC	-7.31
Roic5y	-5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-27.93%
Cagr1y	12.01%
Cagr3y	-11.21%
Cagr5y	-15.76%
EPS Growth Years	0
FCF Growth	59.1%
FCF Growth3 Y	-6.28%
OCF Growth	62.98%
OCF Growth10 Y	-10.34%
OCF Growth3 Y	-1.5%
OCF Growth5 Y	29.44%
Revenue Growth	1.92x
Revenue Growth Q	5.24x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	3.01x
Revenue Growth5 Y	0.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.69
Assets	HKD 1.1B
Cash	HKD 66.1M
Current Assets	HKD 372M
Current Liabilities	HKD 462.8M
Debt	HKD 203.7M
Debt EBITDA	HKD 4.5
Debt Equity	HKD 0.43
Debt FCF	HKD 3.83
Equity	HKD 476.3M
Interest Coverage	-4.17
Liabilities	HKD 588.9M
Long Term Assets	HKD 693.2M
Long Term Liabilities	HKD 126.1M
Net Cash	HKD -137.6M
Net Cash By Market Cap	HKD -84.91
Net Debt Equity	HKD 0.29
Net Debt FCF	HKD 2.59
Tangible Book Value	HKD 318.5M
Tangible Book Value Per Share	HKD 0.06
WACC	4.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	4.53
Net Working Capital	HKD -28.1M
Quick ratio	0.55
Working Capital	HKD -90.8M
Working Capital Turnover	HKD 76.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	HKD 0
Last Dividend	HKD 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.22%
1Y total return	12%
200-day SMA	0.03
3Y total return	-30%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-57.58%
All Time High	2.03
All Time High Change	-98.62%
All Time High Date	2015-06-01
All Time Low	0.02
All Time Low Change	40%
All Time Low Date	2025-04-15
ATR	0
Beta	0
Beta1y	0.39
Beta2y	0.48
Ch YTD	-3.45
High	0.03
High52	0.05
High52 Date	2025-09-18
High52ch	-41.67%
Low	0.03
Low52	0.03
Low52 Date	2025-11-14
Low52ch	12%
Ma50ch	-5.41%
Price vs 200-day SMA	-6.98%
RSI	47.27
RSI Monthly	44.17
RSI Weekly	47.62
Sharpe ratio	0.45x
Sortino ratio	0.89
Tr YTD	-3.45
Tr1m	-6.67%
Tr1w	-3.45%
Tr3m	-6.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -44.9M
Operating margin	-4.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,901,799,777%
Net Borrowing	-79,403,000
Shares Out	5,588,571,777
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 53.2M
Average Volume	1,120,200x
Bv Per Share	0.1
CAPEX	HKD -23.5M
Ch10y	-96.22
Ch1m	-6.67
Ch1w	-3.45
Ch1y	12
Ch3m	-6.67
Ch3y	-30
Ch5y	-57.58
Change	-3.45%
Change From Open	-3.45
Close	0.03
Days Gap	0
Depreciation Amortization	30,571,000
Dollar Volume	42,504
Earnings Date	2026-08-28
EBIT	HKD -44.9M
EBITDA	HKD -14.3M
EPS	HKD -0.08
F Score	4
FCF	HKD 53.2M
FCF EV Yield	23.87x
FCF Per Share	HKD 0.01
Financing CF	-90,163,000
Fiscal Year End	December
Founded	2,011
Goodwill	141,895,000
Income Tax	HKD 27.8M
Investing CF	8,822,000
Is Primary Listing	1
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Last Split Date	2015-01-20
Last Split Type	Forward
Ma150	0.03
Ma150ch	-6.35%
Ma20	0.03
Ma20ch	-5.41%
Net CF	-14,521,000
Next Earnings Date	2026-08-28
Open	0.03
P FCF Ratio	3.05
P OCF Ratio	2.11
Position In Range	33.33
Ppne	411,100,000
Price Date	2026-05-08
Ptbv Ratio	0.51
Relative Volume	1.42x
Revenue	914,709,000x
Tax By Revenue	3.04x
Volume	1,518,000
Z Score	0.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/1312 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/1312 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

HKG/1312 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

-7.0%

50/200-day relationship not available

Beta (5Y)

0.00

Less volatile than the market

Sharpe ratio

0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1312

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1312 stock rating?

hkg/1312 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1312 analysis?

The full report lives at /stocks/hkg/1312/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1312?

The latest report frames hkg/1312 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1312 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.